RU2020111305A - Предупреждение и/или лечение нейродегенеративного заболевания - Google Patents
Предупреждение и/или лечение нейродегенеративного заболевания Download PDFInfo
- Publication number
- RU2020111305A RU2020111305A RU2020111305A RU2020111305A RU2020111305A RU 2020111305 A RU2020111305 A RU 2020111305A RU 2020111305 A RU2020111305 A RU 2020111305A RU 2020111305 A RU2020111305 A RU 2020111305A RU 2020111305 A RU2020111305 A RU 2020111305A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- zeaxanthin
- composition according
- omega
- fatty acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1720119.5 | 2017-12-04 | ||
| GBGB1720119.5A GB201720119D0 (en) | 2017-12-04 | 2017-12-04 | Prevention and/or treatment of neurodegenerative disease |
| PCT/GB2018/051255 WO2019110951A1 (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2020111305A true RU2020111305A (ru) | 2022-01-10 |
Family
ID=60950313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2020111305A RU2020111305A (ru) | 2017-12-04 | 2018-05-10 | Предупреждение и/или лечение нейродегенеративного заболевания |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10835509B2 (enExample) |
| EP (2) | EP3644979B1 (enExample) |
| JP (1) | JP2021505527A (enExample) |
| KR (1) | KR20200095452A (enExample) |
| AU (1) | AU2018379644B2 (enExample) |
| BR (1) | BR112020005132A2 (enExample) |
| CA (1) | CA3071786C (enExample) |
| ES (1) | ES3047101T3 (enExample) |
| GB (2) | GB201720119D0 (enExample) |
| IE (1) | IE87241B1 (enExample) |
| MX (1) | MX2020002458A (enExample) |
| RU (1) | RU2020111305A (enExample) |
| SG (1) | SG11202000786RA (enExample) |
| WO (1) | WO2019110951A1 (enExample) |
| ZA (1) | ZA202000558B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3106957B1 (fr) * | 2020-02-07 | 2024-05-03 | Abdelhadi Zahouani | Composition alimentaire pour stimuler la fonction cognitive et prevenir et limiter le declin cognitif et la demence chez des sujets adultes ou chez des sujets ages denutris |
| US12076299B2 (en) * | 2020-02-20 | 2024-09-03 | Arjuna Natural Pvt Ltd | Composition and method to enhance cognitive support and brain health |
| WO2022244727A1 (ja) * | 2021-05-17 | 2022-11-24 | 小野薬品工業株式会社 | 認知機能を改善するための組成物 |
| JPWO2024143060A1 (enExample) * | 2022-12-26 | 2024-07-04 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006121421A2 (en) | 2004-01-14 | 2006-11-16 | Robert Ritch | Methods and formulations for treating glaucoma |
| US8324276B2 (en) * | 2005-01-24 | 2012-12-04 | Pronova Biopharma Norge As | Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction |
| WO2006116755A2 (en) * | 2005-04-28 | 2006-11-02 | Trustees Of Tufts College | Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function |
| CA2708258C (en) * | 2007-12-17 | 2017-05-09 | Newtricious B.V. | Method of producing egg yolk based functional food product and products obtainable thereby |
| GB201014340D0 (en) | 2010-08-27 | 2010-10-13 | Piraee Mahmood | Nutritional supplement formulation comprising saffron and resveratrol |
| TR201809213T4 (tr) * | 2011-07-07 | 2018-07-23 | Howard Foundation Holdings Ltd | Kamaşma yetersizliğinin iyileştirilmesine yönelik yöntem. |
| DE212013000066U1 (de) * | 2012-07-19 | 2014-09-25 | U.S. Nutraceuticals Llc Dba Valensa International | Krillöl und reagierte Astaxanthinzusammensetzung |
| US20140187648A1 (en) * | 2013-01-03 | 2014-07-03 | Howard Foundation Holdings Ltd. | Identifying Subjects in Need of Treatment |
| GB201300055D0 (en) * | 2013-01-03 | 2013-02-20 | Howard Foundation Holdings Ltd | Identifying subjects in need of treatment |
| CA2907886A1 (en) * | 2013-03-28 | 2014-10-02 | Omniactive Health Technologies Limited | Neuroprotective effect of carotenoids in brain |
| JP6178761B2 (ja) * | 2013-07-10 | 2017-08-09 | ライオン株式会社 | 内服剤 |
| CN109068714A (zh) * | 2016-02-22 | 2018-12-21 | 新粹尔私人有限公司 | 用于预防或治疗神经退行性疾病的组合物 |
-
2017
- 2017-12-04 GB GBGB1720119.5A patent/GB201720119D0/en not_active Ceased
-
2018
- 2018-05-10 BR BR112020005132-2A patent/BR112020005132A2/pt not_active Application Discontinuation
- 2018-05-10 EP EP18725605.2A patent/EP3644979B1/en active Active
- 2018-05-10 CA CA3071786A patent/CA3071786C/en active Active
- 2018-05-10 RU RU2020111305A patent/RU2020111305A/ru unknown
- 2018-05-10 MX MX2020002458A patent/MX2020002458A/es unknown
- 2018-05-10 KR KR1020207007980A patent/KR20200095452A/ko active Pending
- 2018-05-10 AU AU2018379644A patent/AU2018379644B2/en active Active
- 2018-05-10 JP JP2020521460A patent/JP2021505527A/ja active Pending
- 2018-05-10 WO PCT/GB2018/051255 patent/WO2019110951A1/en not_active Ceased
- 2018-05-10 ES ES18725605T patent/ES3047101T3/es active Active
- 2018-05-10 GB GB1807590.3A patent/GB2568986B/en active Active
- 2018-05-10 EP EP25186112.6A patent/EP4599891A3/en active Pending
- 2018-05-10 SG SG11202000786RA patent/SG11202000786RA/en unknown
- 2018-05-15 IE IE20180146A patent/IE87241B1/en unknown
- 2018-05-15 US US15/980,083 patent/US10835509B2/en active Active
-
2020
- 2020-01-28 ZA ZA2020/00558A patent/ZA202000558B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB201807590D0 (en) | 2018-06-27 |
| EP4599891A2 (en) | 2025-08-13 |
| CA3071786A1 (en) | 2019-06-13 |
| EP3644979A1 (en) | 2020-05-06 |
| GB2568986A (en) | 2019-06-05 |
| IE20180146A1 (en) | 2019-06-12 |
| US20190167624A1 (en) | 2019-06-06 |
| JP2021505527A (ja) | 2021-02-18 |
| NZ761512A (en) | 2024-01-26 |
| US10835509B2 (en) | 2020-11-17 |
| SG11202000786RA (en) | 2020-06-29 |
| ES3047101T3 (en) | 2025-12-03 |
| ZA202000558B (en) | 2021-10-27 |
| WO2019110951A1 (en) | 2019-06-13 |
| AU2018379644A1 (en) | 2020-03-19 |
| BR112020005132A2 (pt) | 2020-09-15 |
| KR20200095452A (ko) | 2020-08-10 |
| IE87241B1 (en) | 2021-07-07 |
| GB2568986B (en) | 2019-12-18 |
| GB201720119D0 (en) | 2018-01-17 |
| MX2020002458A (es) | 2020-07-20 |
| EP3644979B1 (en) | 2025-08-06 |
| CA3071786C (en) | 2023-11-14 |
| AU2018379644B2 (en) | 2024-02-08 |
| EP4599891A3 (en) | 2025-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2020111305A (ru) | Предупреждение и/или лечение нейродегенеративного заболевания | |
| ES2564025T3 (es) | Composiciones que comprenden 15-HEPE y métodos de uso de las mismas | |
| Freeman | Omega-3 fatty acids in major depressive disorder. | |
| US20130108706A1 (en) | Dietary formulations | |
| JP2021505527A5 (enExample) | ||
| CA2705936C (en) | Use of omega-3-fatty acids for pain relief | |
| JP2016053065A5 (enExample) | ||
| JP2018517787A5 (enExample) | ||
| CA3129008A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
| JP2017526623A (ja) | 活性物質のミネラル・アミノ酸錯体 | |
| RU2010120706A (ru) | Композиция липоевой кислоты в виде шариков | |
| RS51195B (sr) | Upotreba visoko koncentrovanih kompozicija odabranih n-3-masnih kiselina za lečenje poremećaja centralnog nervnog sistema | |
| US20160296487A1 (en) | Lipid composition for the prevention or treatment of skin problems | |
| KR100858988B1 (ko) | 치료제 | |
| ES2332102T3 (es) | Composicion que contiene acidos grasos omega 3 y acidos grasos omega 6. | |
| JP2023030130A5 (enExample) | ||
| JP7201646B2 (ja) | 経口組成物 | |
| NZ761512B2 (en) | Prevention and/or treatment of neurodegenerative disease | |
| CN108882722A (zh) | 食用油中的按时释放维生素和矿物质 | |
| US12053437B2 (en) | Eye health supplement | |
| US20230263736A1 (en) | Soft gelatin capsules | |
| ES2255653T3 (es) | Capsula de gelatina con vitaminas liposolubles y acidos grasos. | |
| RU2006120614A (ru) | Комбинированный продукт из питательных микроэлементов для дополнительной сбалансированной диеты при возрастных дегенеративных изменениях в области желтого пятна | |
| CN109789178B (zh) | 影响心血管效率的营养补充剂 | |
| Crawford | Another Supplement for CAD Prevention Fails |